![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera Announces Company Name Change to Neothetics, Inc.
12 août 2014 07h00 HE
|
Neothetics
SAN DIEGO, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc., announced today that it has changed its name to Neothetics, Inc. The new name strengthens the company's positioning as a clinical-stage,...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera to Present at the 13th Annual Needham Healthcare Conference
02 avr. 2014 07h00 HE
|
Neothetics
SAN DIEGO, April 2, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera to Present at Cowen and Company Health Care Conference
27 févr. 2014 07h00 HE
|
Neothetics
SAN DIEGO, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera Announces Final Closing of $35.6 Million Series C Financing
11 févr. 2014 07h00 HE
|
Neothetics
SAN DIEGO, Feb. 11, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer
21 nov. 2013 07h00 HE
|
Neothetics
SAN DIEGO, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, today...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring
30 sept. 2013 07h00 HE
|
Neothetics
SAN DIEGO, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, today...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera Announces Second Closing of $27.3 Million Series C Financing
18 juil. 2013 07h00 HE
|
Neothetics
SAN DIEGO, July 18, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on aesthetic and medical indications, today announced that it...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera Announces Notice of Allowance for Key United States Patent Application for LIPO-202, Its Novel Product for Localized Fat Reduction
07 janv. 2013 09h00 HE
|
Neothetics
SAN DIEGO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering formulations and...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera, Inc. Completes $20.6 Million Equity Financing
19 déc. 2012 09h00 HE
|
Neothetics
SAN DIEGO, Dec. 19, 2012 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced investment of $20.6 million in preferred stock equity financing. Additional investment may provide the Company with up to a...
![Neothetics Logo](/news-release/logo/307120/0/307120.jpg?lastModified=12%2F10%2F2016%2001%3A19%3A44&size=2)
Lithera, Inc. Appoints Thomas Wiggans to Board of Directors
04 avr. 2011 09h00 HE
|
Neothetics
SAN DIEGO, April 4, 2011 (GLOBE NEWSWIRE) -- Lithera, Inc. announced today the appointment of Thomas G. Wiggans to its Board of Directors.
"Lithera is making substantial progress with LIPO-102 by...